Telomir Pharmaceuticals (TELO) Company Overview

Profile

Full Name:

Telomir Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 9, 2019

Indexes:

Not included

Description:

Telomir Pharmaceuticals focuses on developing innovative therapies that target telomeres, the protective ends of chromosomes. Their research aims to address age-related diseases and improve healthspan by promoting cellular health and longevity. The company is dedicated to advancing treatments that enhance overall well-being and quality of life.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Telomir Pharmaceuticals?
  • Does Telomir Pharmaceuticals pay dividends?
  • What sector is Telomir Pharmaceuticals in?
  • What industry is Telomir Pharmaceuticals in?
  • What country is Telomir Pharmaceuticals based in?
  • When did Telomir Pharmaceuticals go public?
  • Is Telomir Pharmaceuticals in the S&P 500?
  • Is Telomir Pharmaceuticals in the NASDAQ 100?
  • Is Telomir Pharmaceuticals in the Dow Jones?
  • When was Telomir Pharmaceuticals's last earnings report?
  • When does Telomir Pharmaceuticals report earnings?
  • Should I buy Telomir Pharmaceuticals stock now?

What is the ticker symbol for Telomir Pharmaceuticals?

The ticker symbol for Telomir Pharmaceuticals is NASDAQ:TELO

Does Telomir Pharmaceuticals pay dividends?

No, Telomir Pharmaceuticals does not pay dividends

What sector is Telomir Pharmaceuticals in?

Telomir Pharmaceuticals is in the Healthcare sector

What industry is Telomir Pharmaceuticals in?

Telomir Pharmaceuticals is in the Biotechnology industry

What country is Telomir Pharmaceuticals based in?

Telomir Pharmaceuticals is headquartered in United States

When did Telomir Pharmaceuticals go public?

Telomir Pharmaceuticals's initial public offering (IPO) was on April 9, 2019

Is Telomir Pharmaceuticals in the S&P 500?

No, Telomir Pharmaceuticals is not included in the S&P 500 index

Is Telomir Pharmaceuticals in the NASDAQ 100?

No, Telomir Pharmaceuticals is not included in the NASDAQ 100 index

Is Telomir Pharmaceuticals in the Dow Jones?

No, Telomir Pharmaceuticals is not included in the Dow Jones index

When was Telomir Pharmaceuticals's last earnings report?

Telomir Pharmaceuticals's most recent earnings report was on Feb 28, 2025

When does Telomir Pharmaceuticals report earnings?

The date for Telomir Pharmaceuticals's next earnings report has not been announced yet

Should I buy Telomir Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions